COPDCompEx: A novel composite endpoint for COPD exacerbations to enable faster clinical development-Reference-Cited by-同舟云学术

COPDCompEx: A novel composite endpoint for COPD exacerbations to enable faster clinical development

Published:2020-11 Issue: Volume:173 Page:106175
ISSN:0954-6111
Container-title:Respiratory Medicine
language:en
Short-container-title:Respiratory Medicine

Author:

Vogelmeier Claus F.,Fuhlbrigge Anne,Jauhiainen Alexandra,Scheepers Lieke E.J.M.,Bengtsson Thomas,Peterson Stefan,Karlsson Niklas,Sethi Tariq,Locantore Nicholas,Tal-Singer Ruth,Rennard Stephen,Fagerås Malin,Da Silva Carla A.

Funder

AstraZeneca

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference25 articles.

1. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease Updated;Global Initiative for Chronic Obstructive Lung Disease,2019

2. Budesonide/formoterol via Turbuhaler(R) versus formoterol via Turbuhaler(R) in patients with moderate to severe chronic obstructive pulmonary disease: phase III multinational study results;Fukuchi;Respirology,2013

3. Effect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized study;Sharafkhaneh;Respir. Med.,2012

4. Development of the EXAcerbations of chronic obstructive pulmonary disease tool (EXACT): a patient-reported outcome (PRO) measure;Leidy;Value Health,2010

5. Performance of the EXAcerbations of chronic pulmonary disease tool patient-reported outcome measure in three clinical trials of chronic obstructive pulmonary disease;Leidy;Ann Am Thorac Soc,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial;Archivos de Bronconeumología;2024-07

2. Implementation of digital health technology in clinical trials: the 6R framework;Nature Medicine;2023-08-16

3. An Update on Outcomes for COPD Pharmacological Trials: A COPD Investigators Report - Reassessment of the 2008 American Thoracic Society/European Respiratory Society Statement on Outcomes for COPD Pharmacological Trials;American Journal of Respiratory and Critical Care Medicine;2023-08-15

4. Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre–Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward;American Journal of Respiratory and Critical Care Medicine;2022-02-01

5. A stochastic mixed effects model to assess treatment effects and fluctuations in home‐measured peak expiratory flow and the association with exacerbation risk in asthma;CPT: Pharmacometrics & Systems Pharmacology;2021-12-13